CRISPR-StAR, ViVeritas game-changing technology for in vivo screening published at Nature Biotechnology

The proprietary technology to empower high resolution in vivo CRISPR screening was published in Nature biotechnology. This method, developed in the Elling laboratory while at the Institute of Biotechnology of the Austrian Academy of Sciences (OEAW) expands CRISPR screening to new assays, models, and scale.

For more details visit the publication or see the IMBA/OEAW press release.

https://www.nature.com/articles/s41587-024-02512-9

https://www.oeaw.ac.at/imba/research-highlights/news/next-level-crispr-screening-new-method-for-identifying-cancers-achilles-heels-1